Autism Spectrum Disorder Trial, Recruiting NCT06875843 Sponsor: Vanderbilt University Medical Center Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06875843
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For child participants:

  • The child has been diagnosed with autism spectrum disorder
  • The child is between 2 and 5 years old
  • The child uses no more than 20 words (spoken, signed, or through a communication device) according to their parent or caregiver
  • The child uses fewer than 5 different words during a 15-minute communication observation
  • The child uses at least one consonant sound, either observed directly or reported by a caregiver
  • The child's primary language is English

For caregiver participants:

  • The caregiver has a child who is enrolled in this study (one caregiver per child)
  • The caregiver has enough English language skills to complete surveys

Who may not be able to join:

For child participants:

  • The child has a vision or hearing problem that has not been corrected with glasses, hearing aids, or other support
  • The child has signs of a serious physical condition that significantly affects their movement and motor abilities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 615-936-5114

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 April 2025
Est. completion
1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of children for whom the contingent responses with vocal elicitation strategies condition is successful for increasing quantity of vocalizations; Proportion of children for whom the contingent responses condition is successful for increasing quantity of vocalizations; Proportion of children for whom the contingent responses with vocal elicitation strategies condition provides added value for increasing quantity of vocalizations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov